SG Americas Securities LLC Increases Position in PerkinElmer, Inc. (PKI)
SG Americas Securities LLC increased its position in PerkinElmer, Inc. (NYSE:PKI) by 162.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 22,913 shares of the medical research company’s stock after purchasing an additional 14,181 shares during the quarter. SG Americas Securities LLC’s holdings in PerkinElmer were worth $1,675,000 as of its most recent SEC filing.
Other hedge funds have also recently made changes to their positions in the company. State of Wisconsin Investment Board acquired a new stake in PerkinElmer in the third quarter worth about $1,673,000. Bessemer Group Inc. increased its position in PerkinElmer by 22.2% in the third quarter. Bessemer Group Inc. now owns 27,149 shares of the medical research company’s stock worth $1,873,000 after purchasing an additional 4,936 shares during the period. Sivik Global Healthcare LLC increased its position in PerkinElmer by 12.5% in the third quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the medical research company’s stock worth $6,207,000 after purchasing an additional 10,000 shares during the period. King Luther Capital Management Corp increased its position in PerkinElmer by 1.3% in the third quarter. King Luther Capital Management Corp now owns 2,562,833 shares of the medical research company’s stock worth $176,759,000 after purchasing an additional 32,248 shares during the period. Finally, Toronto Dominion Bank increased its position in PerkinElmer by 26.4% in the second quarter. Toronto Dominion Bank now owns 35,925 shares of the medical research company’s stock worth $2,447,000 after purchasing an additional 7,505 shares during the period. Hedge funds and other institutional investors own 90.98% of the company’s stock.
Several research firms have recently issued reports on PKI. Robert W. Baird restated a “buy” rating and set a $72.00 target price on shares of PerkinElmer in a research report on Friday, October 20th. Bank of America upgraded PerkinElmer from an “underperform” rating to a “neutral” rating and set a $78.00 target price for the company in a research report on Tuesday, December 19th. Barclays boosted their target price on PerkinElmer from $69.00 to $73.00 and gave the stock an “underweight” rating in a research report on Friday, January 26th. ValuEngine lowered PerkinElmer from a “buy” rating to a “hold” rating in a research report on Friday, December 1st. Finally, Jefferies Group restated a “hold” rating and set a $70.00 target price on shares of PerkinElmer in a research report on Friday, October 20th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the company. PerkinElmer currently has a consensus rating of “Hold” and an average price target of $76.85.
PerkinElmer (NYSE:PKI) last issued its quarterly earnings data on Thursday, January 25th. The medical research company reported $0.97 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.94 by $0.03. PerkinElmer had a return on equity of 13.30% and a net margin of 12.97%. The business had revenue of $641.63 million during the quarter, compared to analyst estimates of $619.14 million. During the same period in the previous year, the firm earned $0.83 EPS. PerkinElmer’s quarterly revenue was up 13.2% compared to the same quarter last year. research analysts anticipate that PerkinElmer, Inc. will post 3.52 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 10th. Investors of record on Friday, April 13th will be given a $0.07 dividend. The ex-dividend date of this dividend is Thursday, April 12th. This represents a $0.28 annualized dividend and a dividend yield of 0.39%. PerkinElmer’s dividend payout ratio is presently 10.61%.
In other PerkinElmer news, insider Andrew Okun sold 12,680 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $72.00, for a total value of $912,960.00. Following the sale, the insider now owns 25,121 shares in the company, valued at approximately $1,808,712. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Alexis P. Michas sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $73.18, for a total value of $365,900.00. The disclosure for this sale can be found here. Insiders sold a total of 64,559 shares of company stock valued at $4,591,077 over the last quarter. 2.20% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.thecerbatgem.com/2018/02/09/sg-americas-securities-llc-increases-position-in-perkinelmer-inc-pki.html.
PerkinElmer Company Profile
PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.
Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.